Melt&Marble Secures €7.3M Series A Led by Industrifonden

Why It Matters

The capital injection accelerates a low‑carbon alternative to animal‑derived fats, positioning Melt&Marble to capture growing demand in clean‑label food and cosmetics markets.

Key Takeaways

• Series A totals €7.3 million
• Led by Industrifonden, includes EIC Fund
• Strategic investors Beiersdorf, Valio join round
• Precision fermentation targets designer fats market
• Funding accelerates scale‑up and regulatory approvals

Pulse Analysis

Precision fermentation is reshaping the ingredients landscape by enabling companies to engineer fats molecule‑by‑molecule. Melt&Marble’s technology replaces traditional animal or vegetable sources with micro‑bial production, delivering consistent functionality while cutting greenhouse‑gas emissions. As consumers and regulators push for cleaner, traceable supply chains, designer fats—tailored for melt point, texture, and nutritional profile—are becoming premium commodities in both food formulations and personal‑care products.

The €7.3 million Series A round reflects a convergence of venture capital, public funding, and industry partners. Industrifonden’s lead role signals confidence in the Swedish biotech ecosystem, while the European Innovation Council Fund adds a policy‑driven endorsement of sustainable innovation. Strategic investors Beiersdorf and Valio bring market insight and potential off‑take agreements, shortening the path from lab to shelf. The involvement of Chalmers‑linked backers further embeds academic expertise, ensuring the science stays ahead of regulatory scrutiny.

For the broader market, Melt&Marble’s financing marks a milestone in the commercialization of bio‑engineered fats. The capital will fund pilot‑scale fermenters, accelerate regulatory submissions, and expand the company’s IP portfolio. If successful, the firm could disrupt multi‑billion‑dollar segments, offering food manufacturers a way to lower saturated‑fat content without sacrificing taste, and giving cosmetics brands a renewable alternative to palm‑derived ingredients. The move also highlights a growing investor appetite for climate‑positive biotech solutions that marry scalability with consumer‑grade performance.

Deal Summary

Swedish biotech Melt&Marble announced a €7.3 million Series A round to scale its precision‑fermentation platform for designer fats. The round was led by Industrifonden with participation from the European Innovation Council Fund, Beiersdorf, Valio and Chalmers.